Renaissance Technologies
JBIO

Renaissance Technologies’s Jade Biosciences JBIO Stock Holding History

Renaissance Technologies’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Sell
73,591
-61,448
-46% -$1.28M ﹤0.01% 2078
2026
Q1 		$1.9M Buy
135,039
+65,438
+94% +$948K ﹤0.01% 1925
2025
Q4 		$1.07M Buy
+69,601
New +$816K ﹤0.01% 2233
2025
Q2 		– Sell
-1,543
Closed -$136K – 3547
2025
Q1 		$136K Buy
1,543
+269
+21% +$23.6K ﹤0.01% 3147
2024
Q4 		$118K Buy
1,274
+763
+149% +$65.8K ﹤0.01% 3264
2024
Q3 		$37.4K Buy
+511
New +$33K ﹤0.01% 3377
2024
Q2 		– Sell
-214
Closed -$222K – 3487
2024
Q1 		$222K Buy
+214
New +$163K ﹤0.01% 3191
2023
Q2 		– Sell
-503
Closed -$355K – 3905
2023
Q1 		$355K Sell
503
-14
-3% -$11.6K ﹤0.01% 3046
2022
Q4 		$530K Buy
+517
New +$375K ﹤0.01% 2927

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies's JBIO Position: Q2 2026 in Review

Renaissance Technologies reduced its Jade Biosciences (JBIO) stake by 46% in Q2 2026, selling an estimated $1.28M and leaving 73,591 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2078.

Renaissance Technologies first reported a position in JBIO in Q4 2022 and has held it in 9 quarters since. The position peaked at $1.9M in Q1 2026. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Renaissance Technologies held 73,591 shares of Jade Biosciences worth $1.64M as of Q2 2026.
  • Renaissance Technologies sold 61,448 Jade Biosciences shares in Q2 2026, an estimated $1.28M.
  • Jade Biosciences made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2078 holding.
  • Renaissance Technologies first reported a position in Jade Biosciences in Q4 2022 and has held it in 9 quarters since.
  • Renaissance Technologies's Jade Biosciences position peaked at $1.9M in Q1 2026.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.